Table 2.
Comparison of pre- and intraoperative parameters
| Variable | TUC group (n = 357) | Non-TUC group (n = 1,206) | P-value |
|---|---|---|---|
| Preoperative parameters | |||
| Total IPSS | 19.5 ± 8.0 | 18.7 ± 7.8 | 0.116 |
| QoL score | 4.2 ± 1.1 | 4.1 ± 1.2 | 0.111 |
| PSA (ng/mL) | 5.4 ± 4.8 | 3.8 ± 4.5 | < 0.001 |
| Qmax (mL/sec) | 9.0 ± 4.4 | 9.6 ± 4.9 | 0.052 |
| Postvoid residual volume (mL) | 68.8 ± 91.3 | 67.5 ± 90.5 | 0.848 |
| Total prostate volume (mL) | 89.5 ± 44.7 | 66.0 ± 32.6 | < 0.001 |
| Transition zone volume (mL) | 57.3 ± 34.9 | 37.7 ± 24.2 | < 0.001 |
| Intraoperative parameters | |||
| Operation time (min) | 74.9 ± 36.6 | 49.1 ± 23.9 | < 0.001 |
| Enucleation time (min) | 41.0 ± 18.3 | 32.1 ± 15.0 | < 0.001 |
| Morcellation time (min) | 14.5 ± 11.4 | 8.8 ± 6.9 | < 0.001 |
| Enucleation weight (g) | 37.1 ± 29.1 | 21.4 ± 26.6 | < 0.001 |
| Intraoperative capsule perforation | 2 (0.6) | 5 (0.4) | 0.662 |
Values are presented as mean±standard deviation or number of patients (%).
TUC, transurethral coagulation; IPSS, International Prostate Symptom Score; QoL, quality of life; PSA, prostate-specific antigen; Qmax, maximum flow rate.